News & Events
FDA-NIH Joint Leadership Council: Stakeholders Meeting
The Food and Drug Administration (FDA) hosted a public meeting, in conjunction with the National Institutes of Health (NIH), to solicit comments from interested persons on how the agencies can more effectively collaborate to advance the translation of biomedical research discoveries into approved diagnostics and therapies as well as promote science to enhance the evaluation tools used for regulatory review. A newly formed NIH-FDA Joint Leadership Council will help ensure that regulatory considerations form an increasing component of biomedical research planning, and that the latest science is integrated into the regulatory review process.
This meeting was held on June 2, 2010 from 8:30 a.m. to 12:30 p.m. at FDA, 10903 New Hampshire Ave., Bldg. 31, rm. 1503C, Silver Spring, MD 20993-0002.
The Federal Register notice provides information about meeting registration and the public participation process. It is available at http://www.gpo.gov/fdsys/pkg/FR-2010-05-10/html/2010-11008.htm.
For further information, you can contact Rakesh Raghuwanshi, Office of the Commissioner, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, rm. 4283, Silver Spring, MD 20993-0002, 301-796-4769, e-mail: email@example.com.